.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
Dow
Deloitte
Fuji
Moodys
Daiichi Sankyo
Novartis
UBS
Argus Health

Generated: November 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Bristol Myers

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
208III5/24/1956BRISTOL LABORATORIES INC DIV BRISTOL MYERS COTESTING FACILITIES FOR RAW MATERIALS & FINISHED GOODS
226III5/24/1956BRISTOL LABORATORIES INC DIV BRISTOL MYERS COCALCIUM AMPHOMYCIN OINTMENT
608I5/31/1963BRISTOL LABORATORIES INC DIV BRISTOL MYERS COACTINOGAN (NSC 54496 D)
609I6/3/1963BRISTOL LABORATORIES INC DIV BRISTOL MYERS COA649 (NSC 38270)
612I7/30/1963BRISTOL LABORATORIES INC DIV BRISTOL MYERS COMITOMYCIN C (NSC 26,980)
632I8/9/1963BRISTOL LABORATORIES INC DIV BRISTOL MYERS COCURRICULA VITAE OF CLINICAL INVESTIGATORS
1075I8/7/1967BRISTOL LABORATORIES INC DIV BRISTOL MYERS CONEOCARZINOSTATIN
2038III1/10/1973BRISTOL LABORATORIES INC DIV BRISTOL MYERS COCARMUSTINE (BCNU) BULK & CARMUSTINE (BCNU) FOR INJ
6464III6/20/1986BRISTOL LABORATORIES INC DIV BRISTOL MYERS COMETHODS, FACILITIES, AND CONTROLS IN MAYAGUEZ, PUERTO RICO
8098IV5/30/1989BRISTOL MYERS PRODUCTS DIV BRISTOL MYERS COSTERILE PROCESSING FACILITY IN JAPAN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Chubb
Julphar
Covington
Teva
McKinsey
Fuji
Cerilliant
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot